Theralase Technologies Inc (TLTFF)

[Anesthesia 2007]

I’m quite shocked at the markets initial reaction to this! It wasn’t a great PR today but it wasn’t bad either. The 1st 3 patients were treated with a lower dose therapy. It would have been great if all of them were still cancer free but Phase 1’s purpose is to gather data to fine tune a treatment protocol for Phase 2 that will have maximal efficacy for treatment of NMIBC. They will take this lackluster data and the data from the next 6 patients to create a more robust protocol for Phase 2 next year. Am I missing something?!